Target intelligence / Profile preview

Intestinal mucosal barrier and motility

Molecular classification
Other
01

Overview

The intestinal mucosal barrier and motility represent a complex physiological system essential for maintaining gastrointestinal homeostasis and systemic health. The mucosal barrier consists of a physical layer of mucus and epithelial cells connected by tight junctions, which selectively allow nutrient absorption while preventing the translocation of pathogens and toxins into the bloodstream (Source: PubMed, PMID: 23524162). Intestinal motility refers to the coordinated contraction and relaxation of smooth muscles, governed by the enteric nervous system, to move luminal contents through the digestive tract (Source: StatPearls, NBK553060). Dysregulation of these processes is central to the pathogenesis of various conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and celiac disease. Therapeutic interventions often target specific components of this system, such as tight junction regulators to decrease permeability or receptor agonists/antagonists to modulate transit time and secretion (Source: NIH, PMC4253991).

Other names
Gut barrier functionGastrointestinal motilityIntestinal permeabilityGI barrier and transit
02

Mechanism of action

Drugs targeting this system act through various mechanisms including the modulation of tight junction proteins (e.g., zonulin antagonism), activation of chloride channels or guanylate cyclase-C to increase secretion and motility, and agonism of opioid or serotonin receptors to regulate peristaltic speed.

03

Biological functions

Barrier functionPeristalsisImmune responseNutrient absorptionSignal transduction
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeCeliac diseaseGastrointestinal motility disordersInfection
05

Safety considerations

Bacterial translocationElectrolyte imbalanceChronic constipation or diarrheaMalabsorption syndromesRisk of systemic inflammation
06

Interacting drugs

Larazotide

5 more in the full profile.

07

Biomarkers

ZonulinFecal calprotectinLactulose-to-mannitol ratioPlasma citrullineIntestinal fatty acid-binding protein (I-FABP)

Beyond the preview

Go deeper on Intestinal mucosal barrier and motility.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal mucosal barrier and motility.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call